Hyeon-Su Im

8PUBLICATIONS
99CO-AUTHORS
Pacific Peoples social determinants of healthCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Korean language
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 08, 2026
Impact of unmet needs on health-related quality of life among cancer survivors in Ulsan, Korea.

|Nov 13, 2025
Bevacizumab plus Erlotinib in Advanced Solid Cancers with Krebs Cycle Gene Mutations: A Multicenter Phase II Study (BRISK; KCSG AL22-16).

Hyehyun Jeong, Changhoon Yoo, Shinkyo Yoon

|Oct 02, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and Oxaliplatin.

Hongsik Kim, Chiyoon Oum, Soo Ick Cho

|Jan 17, 2025
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).

In-Ho Kim, Seung Joo Kang, Wonyoung Choi

|Aug 29, 2023
Development and pilot study of "Smart Cancer Care": a platform for managing side effects of chemotherapy.

Cheolkyung Sin, Hyeyeong Kim, Hyeon-Su Im

|May 02, 2023
Erratum: Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach.

Tae-Han Kim, In-Ho Kim, Seung Joo Kang

Pageof 2

Frequent Collaborators

3 joint publications

Tae-Han Kim

3 joint publications

In-Ho Kim

3 joint publications

Seung Joo Kang

3 joint publications

Bum Jun Kim